Skip to content

Understanding the Rules: How are Probiotics Regulated?

4 min read

With the global probiotic market valued at approximately USD 87.70 billion in 2023 and growing, understanding how are probiotics regulated is more important than ever. The regulatory pathway for a probiotic product is not a single, uniform process but is instead defined by its intended use, whether it's marketed as a food, a dietary supplement, or a drug.

Quick Summary

Probiotic regulation is complex and depends on the product's intended use, falling under different categories like foods, dietary supplements, or drugs, each with distinct rules regarding safety, claims, and labeling oversight by agencies such as the FDA and FTC.

Key Points

  • Intended Use is Key: Probiotic regulation depends on whether the product is marketed as a food, a dietary supplement, or a drug.

  • US Regulation is Divided: The FDA and FTC share oversight, with the FDA handling product classification and the FTC policing advertising claims.

  • Strict vs. Relaxed Rules: Products making disease-related claims are regulated as drugs, requiring rigorous clinical trials and FDA approval, while dietary supplements have fewer pre-market requirements.

  • Claim Substantiation is Required: Manufacturers must provide scientific evidence to back up any claims made, and dietary supplements must include an FDA disclaimer.

  • Global Standards Differ: There is no universal framework for probiotics, with regulations varying significantly between regions like the US, EU, and Canada.

  • Labeling is Crucial: High-quality probiotic labels should specify the genus, species, strain, and CFU count at the time of expiration for full transparency.

  • Quality and Efficacy Concerns Exist: The less stringent regulation for supplements means product quality, viability, and efficacy can vary, especially when used for medical purposes.

In This Article

The Deciding Factor: Intended Use

Unlike pharmaceuticals, which undergo a single, rigorous pre-market approval process, probiotic products are regulated based on their intended use, a fact that creates a multifaceted and sometimes confusing regulatory environment. This intended use dictates whether the product is classified as a conventional food, a dietary supplement, or a drug, with each category having different levels of regulatory scrutiny and claim restrictions.

The US Regulatory Landscape: FDA and FTC Oversight

In the United States, two primary federal agencies oversee the regulation and marketing of probiotics: the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC).

  • FDA Regulation: The FDA's oversight of probiotic products is divided among its regulatory categories. Most probiotic products are sold as dietary supplements or are incorporated into food products, such as yogurt and kefir.
    • Dietary Supplements: For these products, manufacturers are responsible for ensuring the safety and truthful, non-misleading nature of their claims. Pre-market approval by the FDA is not required, although manufacturers must notify the FDA if a product contains a new dietary ingredient. Regulations for Current Good Manufacturing Practice (CGMP) apply to ensure identity, purity, quality, and composition.
    • Drug Products: If a probiotic product is marketed with claims to treat, cure, or prevent a disease, it must be approved as a drug. This requires rigorous clinical trials to prove both safety and efficacy, a process with much higher regulatory standards.
  • FTC Regulation: The FTC is responsible for regulating the advertising and marketing claims made about probiotic products. The FTC ensures that all claims, particularly those related to health benefits, are truthful, not misleading, and backed by competent and reliable scientific evidence. This is a crucial layer of protection that addresses advertising practices rather than the product's inherent safety.

Claims and Labeling: The Rules of Communication

For dietary supplements, manufacturers can make "structure/function" claims, which describe the product's role in affecting the body's structure or function (e.g., "supports healthy digestion"). However, these labels must carry a mandatory disclaimer stating, "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease". Health claims, which describe a relationship between a food/supplement ingredient and a reduced risk of a disease, require specific FDA authorization.

Labeling standards for probiotics are also a critical concern for consumer transparency. Industry guidelines, supported by organizations like the International Probiotics Association (IPA), recommend that labels include:

  • Genus, species, and strain designation for each microorganism.
  • The minimum number of viable cells in Colony Forming Units (CFU) per serving, guaranteed through the shelf life.
  • Clear storage instructions.

Comparison of Regulatory Categories in the US

Feature Dietary Supplement Drug Conventional Food
Pre-Market Approval Not required for most products; required for 'new' ingredients Required; must prove safety and efficacy through clinical trials Generally not required; some ingredients require evaluation for 'Generally Recognized as Safe' (GRAS) status
Safety Oversight Manufacturer is responsible for safety; FDA monitors post-market adverse events FDA pre-market and post-market safety monitoring FDA ensures food safety standards are met
Allowed Claims Structure/function claims with disclaimer; must be truthful and substantiated Specific disease claims after extensive clinical proof Nutrient content claims; cannot make disease claims
Labeling Lists dietary ingredients; recommended to use CFU count and expiration potency Detailed information on efficacy, safety, and dosage Nutrition facts panel; may or may not specify strain in foods

Global Variation and Challenges in Regulation

There is no globally harmonized standard for how probiotics are regulated, leading to significant variations across regions.

  • European Union (EU): Historically strict, the EU has made it difficult to get health claims for probiotics approved by the European Food Safety Authority (EFSA). Some member states have since taken individual approaches, allowing the term "probiotic" on labels under specific conditions. The EU maintains a list of microbial cultures with a Qualified Presumption of Safety (QPS).
  • Canada: Probiotics can fall under the Natural Health Products (NHP) category, which requires pre-market approval and allows for specific, evaluated claims related to health promotion or risk reduction.
  • Regulatory Challenges: The current global environment for probiotic regulation faces several challenges, including:
    • A lack of clear rules that account for the complex, strain-specific nature of living organisms.
    • Issues with product quality control, as manufacturing processes heavily influence efficacy.
    • Inconsistencies in labeling across the market, making it difficult for consumers to make informed choices.

Conclusion: A Consumer's Role in a Complex Market

How are probiotics regulated? The answer is that it's complicated, depending heavily on the specific product and its intended use, as well as its location. While regulatory bodies like the FDA and FTC provide a framework for consumer protection, significant differences exist between categories like dietary supplements and drugs. Consumers must understand these distinctions to evaluate product claims critically. When considering a probiotic for a specific health issue, consulting a healthcare provider is essential, as only a medically prescribed drug will have proven efficacy and safety under the highest regulatory standards. Consumers should prioritize products from reputable manufacturers that provide transparent labeling, including strain designation and potency, to ensure they are getting what they pay for.


For more information on the guidelines, see the International Scientific Association for Probiotics and Prebiotics (ISAPP) infographic.

Frequently Asked Questions

The FDA regulates probiotic supplements under the Dietary Supplement Health and Education Act (DSHEA). Manufacturers are responsible for ensuring the product is safe and that its claims are truthful and not misleading, without needing pre-market approval.

A 'structure/function' claim describes how a product affects the structure or function of the body (e.g., 'supports digestive health') and requires an FDA disclaimer. A 'disease' claim suggests the product can treat or prevent a disease and is only permissible for products regulated as drugs.

No, probiotic dietary supplements do not require FDA approval before they are marketed. The manufacturer is responsible for the product's safety and the truthfulness of its claims.

European regulation is complex and not harmonized. The European Food Safety Authority (EFSA) assesses health claims, most of which have been rejected. Member states may have different rules, and there was a past ban on using the term 'probiotic' on labels in the EU.

The FTC enforces truth-in-advertising laws for probiotic products. It requires manufacturers to have competent and reliable scientific evidence to support any claims made in their marketing and advertising.

Yes, it is very important. The effects of probiotics are often strain-specific, so knowing the exact strain is necessary to link a product to clinical evidence of its benefits. Reputable manufacturers list the genus, species, and strain on their labels.

While generally safe for healthy individuals, probiotics can pose a risk to certain vulnerable populations, such as premature infants or immunocompromised patients. The FDA has issued warnings about the risks for premature infants, emphasizing the need for professional medical guidance.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.